C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof

Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
11/2004
11/25/2004	WO2004101582A2 Thermolabile hydroxyl protecting groups and methods of use
11/25/2004	US20040236135 Preparation and use of alpha-keto phosphonates
11/25/2004	US20040235782 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/25/2004	US20040235773 Stability, nuclease, solubility, cell permeability, nontoxic; polymer conjugates containing nucleotides and/or oligonucleotides; antisense agents
11/25/2004	US20040235762 Host vs. graft disease, leukemia, lymphoma; autoimmune disorders; fungicides; antitumor and antiproliferative agents
11/25/2004	US20040235761 Novel virus proliferaton inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
11/25/2004	US20040235084 biomimic cofactor; 3-substituted pyridium compounds; nicotinamides N-substituted with benzyl or polyoxyethylene glycol derivatives; bipyridyl rhodium hydride complex catalyst for reduction of the cofactor; polymer matrix; economical in large scale; biosensor or a chemical membrane bioreactor
11/25/2004	CA2525907A1 Rapamycin carbohydrate derivatives
11/24/2004	EP1478656A2 Oligonucleotide compositions with enhanced efficiency
11/24/2004	EP1478322A2 Beta-2'-OR 3'-HALONUCLEOSIDES
11/24/2004	EP0929538B1 O?2 -arylated or o?2 -glycosylated 1-substituted diazen-1-ium-1,2-diolates and o?2 -substituted 1- (2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
11/24/2004	CN1549819A 4'-deoxy-4'-(s)-amino avermectin derivatives
11/24/2004	CN1176936C Chaplamycin derivative and medicinal composition containing the same
11/23/2004	US6822090 Generation of preferential uridine derivative; obtain reaction mixture, expose to tertiary amine, dehydrating reactant and ammonia, recover cytidine derivative
11/23/2004	US6822089 From corresponding ribonucleosides by forming 3-tert-butylphenoxythiocarbonyl derivatives and effecting radical deoxygenation; solid phase synthesis
11/23/2004	US6821306 Generating preferential crystals of disodium 5'- guanylate and disodium 5'-inosinate; obtain mixed solution of disodium 5'-guanylate and disodium 5'- inosinate, heat, form slurry, recover crystals
11/23/2004	CA2294158C Natural antitumor or antiviral substances and use of the same
11/18/2004	WO2004099131A2 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna
11/18/2004	WO2004028454A3 1, 3, 5-triazines for treatment of viral diseases
11/18/2004	US20040230053 Production method of 5'-acyloxynucleoside compound
11/18/2004	US20040230052 coupling a nucleoside monomer having a carbonate protected hydroxyl group to a free hydroxyl group on a support-bound nucleoside monomer, coupling reaction gives rise to a phosphite triester bond between the support-bound nucleoside monomer and the coupled nucleoside; deprotecting; oxidizing phosphite
11/18/2004	US20040229840 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
11/18/2004	US20040229839 Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
11/18/2004	US20040229838 Purine derivatives
11/18/2004	US20040229235 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
11/18/2004	CA2531869A1 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna
11/17/2004	EP1476455A1 PARTIAL AND FULL AGONISTS OF A sb 1 /sb ADENOSINE RECEPTORS
11/17/2004	EP1476407A2 Methods of producing phosphitylated compounds
11/17/2004	EP1476169A1 Methods of inhibiting orthopoxvirus replication with nucleoside compounds
11/17/2004	EP0832092B1 Orally active adenosine kinase inhibitors
11/17/2004	EP0679160B1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
11/17/2004	CN1547585A Inosine L-arginine salt and uses thereof
11/17/2004	CN1176097C Method for purifying 5'-protected 2'-deoxypurine nucleoside
11/17/2004	CN1176096C Technology for producing AR with IR as initiation material by liquid ammonia process
11/17/2004	CN1175758C Separating and extracting method for date cyclic nucleotide syrup, dietary fibre and date wax
11/16/2004	US6818759 Ribozymes; antisense oligonucleotides; hammerhead/hairpin motifs
11/16/2004	US6818629 Administration of a pharmaceutical formulation comprising a hydrolysis-resistant p2y receptor agonist to stimulate the removal of pathological extraneous fluid from the subretinal and retinal spaces; dinucleoside polyphosphate compound
11/16/2004	US6818399 Electrophoretic tag (e-tag) probes; detection involves the release of identifying tags as a consequence of target recognition
11/11/2004	WO2004096824A2 Nucleoside derivative, modified oligonucleotide, method for their synthesis and applications thereof
11/11/2004	WO2004096197A2 5-aza-7-deazapurine nucleosides for treating flaviviridae
11/11/2004	WO2004096149A2 Industrially scalable nucleoside synthesis
11/11/2004	WO2004096138A2 [18f]-furanosylpurine derivatives and uses thereof
11/11/2004	WO2003072066A3 Compositions and methods for the treatment of glaucoma and ocular hypertension
11/11/2004	US20040225119 Fluorescent dyes for use as diagnostic/signalling tool in nucleotide sequence analysis
11/11/2004	US20040225002 Derivatives of isoindigo, indigo and indirubin and methods of treating cancer
11/11/2004	CA2524585A1 Nucleoside derivative, modified oligonucleotide, method for their synthesis and applications thereof
11/09/2004	US6815542 Nucleoside compounds and uses thereof
11/04/2004	WO2004094646A1 Xyloglucan conjugates useful for modifying cellulosic textiles
11/04/2004	WO2004094447A1 Thionucleoside s-nitrosyl derivative
11/04/2004	WO2004094345A2 Protected monomers
11/04/2004	WO2004012687A3 Crystalline and amorphous forms of beta-l-2'-deoxythymidine
11/04/2004	WO2004003000A3 1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
11/04/2004	US20040220395 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
11/04/2004	US20040220134 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040219645 Polyketides and their synthesis
11/04/2004	DE10315772A1 Chemische Verbindung und Verfahren für den intramolekularen Energietransfer zur Abspaltung von labilen funktionellen Gruppen aus chemischen Verbindungen Chemical compound and method for the intramolecular energy transfer to the cleavage of labile functional groups from chemical compounds
11/04/2004	CA2523263A1 Xyloglucan conjugates useful for modifying cellulosic textiles
11/04/2004	CA2522349A1 Protected monomers
11/03/2004	EP1316559B1 Adenosine derivatives and use thereof
11/03/2004	EP1267892B1 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
11/02/2004	US6812342 Diffuse across cell membranes of fully intact cells and regenerate their parent molecules by cellular esterase hydrolysis
11/02/2004	US6812243 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation
11/02/2004	US6812219 Methods and compositions for treating flaviviruses and pestiviruses
11/02/2004	US6811979 Fluorescent nucleobase conjugates having anionic linkers
11/02/2004	US6811975 Phosphorothioate oligonucleotides having modified internucleoside linkages
11/02/2004	CA2103454C Macrocyclic immunomodulators
10/2004
10/28/2004	WO2004092191A2 Polymeric oligonucleotide prodrugs
10/28/2004	WO2004058791A3 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
10/28/2004	WO2003042657A3 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
10/28/2004	US20040215031 Functionalized silicon compounds and methods for their synthesis and use
10/28/2004	US20040215012 nucleosides; fluorescent in situ hybridization; for production of combinatorial libraries
10/28/2004	US20040215010 Universal solid supports for solid phase oligosynthesis and methods for their preparation and use
10/28/2004	US20040214844 N4-acylcytosine nucleosides for treatment of viral infections
10/28/2004	US20040214291 Preparing deoxyribonucleotides in vitro; isolate ribonucleotide from yeast, phosphorylate, convert to deoxyribonucleotide via exposure to ribonucleotide reductase, recover product; cell free DNA synthesis
10/28/2004	US20040214199 comprising protected hydrazino, oxyamino and carbonyl-based groups biochemical immobilization; solid phase synthesis
10/28/2004	US20040214019 Covalently attaching to the surface a functionalized silicon compound include at least one activated silicon group and at least one derivatizable functional group
10/28/2004	CA2520550A1 Polymeric oligonucleotide prodrugs
10/27/2004	EP1471071A1 Production method of 5'-acyloxynucleoside compound
10/27/2004	EP1470148A2 Double-stranded oligonucleotides
10/27/2004	EP1470114A1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones
10/27/2004	EP1469864A1 Compounds useful as a-3 adenosine receptor agonists
10/27/2004	CN1539846A Technique for preparing 5'nucleotide bi-sodium
10/27/2004	CN1539845A Method for preparing beta-thymidine
10/26/2004	US6809195 Comprises a modified phosphoramidite protocol in which oxidation and capping steps are combined into a single step; increased efficiency; solid phase synthesis
10/26/2004	US6809083 Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
10/26/2004	US6808888 Amplificaton of nucleotide sequences present in sample; provide sample containing nucleotide sequnces, incubate with primers, amplify sequences, detect amplified product
10/26/2004	CA2224155C 1-(2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranosyl)cytosine
10/26/2004	CA2111283C Process for preparation of indolopyrrolocarbazole derivatives
10/21/2004	WO2004090154A2 Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis
10/21/2004	WO2004089968A1 Process for producing 2'-deoxy-2'-fluorouridine
10/21/2004	WO2004089529A1 Method for the intramolecular energy transfer for the cleavage of labile functional group from biomolecules and the protected biomolecules
10/21/2004	WO2004009611A3 Multiple layer membrane and method for fabrication thereof
10/21/2004	WO2004009609A3 Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
10/21/2004	WO2003072757A9 Nucleotide mimics and their prodrugs
10/21/2004	US20040210045 Nucleic acid labeling compounds
10/21/2004	US20040209797 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells
10/21/2004	US20040209353 Apparatus which utilizes ribozymes, DNAzymes or catalytic antibodies to detect pathogens in blood products
10/21/2004	US20040209332 Process for manufacturing morpholino-nucleotides, and use thereof for the analysis of and labelling of nucleic acid sequences
10/21/2004	CA2521130A1 Acyl-phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis

1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 201